EE200100151A - Toimeaine pulmonaalne kohaletoimetamine kuivpulbriga - Google Patents

Toimeaine pulmonaalne kohaletoimetamine kuivpulbriga

Info

Publication number
EE200100151A
EE200100151A EEP200100151A EEP200100151A EE200100151A EE 200100151 A EE200100151 A EE 200100151A EE P200100151 A EEP200100151 A EE P200100151A EE P200100151 A EEP200100151 A EE P200100151A EE 200100151 A EE200100151 A EE 200100151A
Authority
EE
Estonia
Prior art keywords
active ingredient
dry powder
pulmonary delivery
pulmonary
delivery
Prior art date
Application number
EEP200100151A
Other languages
English (en)
Estonian (et)
Inventor
Clark Andrew
Kuo Mei-Chang
Lalor Cecily
John Aldous Barry
Original Assignee
Inhale Therapeutic Systems, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inhale Therapeutic Systems, Inc. filed Critical Inhale Therapeutic Systems, Inc.
Publication of EE200100151A publication Critical patent/EE200100151A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
EEP200100151A 1998-09-14 1999-09-13 Toimeaine pulmonaalne kohaletoimetamine kuivpulbriga EE200100151A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10016398P 1998-09-14 1998-09-14
PCT/US1999/021109 WO2000015262A1 (en) 1998-09-14 1999-09-13 Dry powder active agent pulmonary delivery

Publications (1)

Publication Number Publication Date
EE200100151A true EE200100151A (et) 2002-06-17

Family

ID=22278404

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100151A EE200100151A (et) 1998-09-14 1999-09-13 Toimeaine pulmonaalne kohaletoimetamine kuivpulbriga

Country Status (44)

Country Link
EP (1) EP1117442A1 (lt)
JP (1) JP2002524535A (lt)
KR (1) KR20010075063A (lt)
CN (1) CN1317977A (lt)
AP (1) AP1374A (lt)
AR (1) AR022090A1 (lt)
AU (1) AU753014B2 (lt)
BG (1) BG105430A (lt)
BR (1) BR9913722A (lt)
CA (1) CA2343920A1 (lt)
CO (1) CO5130023A1 (lt)
CZ (1) CZ2001829A3 (lt)
DZ (1) DZ2892A1 (lt)
EA (1) EA003476B1 (lt)
EE (1) EE200100151A (lt)
GE (1) GEP20043257B (lt)
GT (1) GT199900156A (lt)
HK (1) HK1042231A1 (lt)
HN (1) HN1999000159A (lt)
HR (1) HRP20010189A2 (lt)
HU (1) HUP0103837A3 (lt)
ID (1) ID28845A (lt)
IL (2) IL141562A0 (lt)
IS (1) IS5878A (lt)
LT (1) LT4897B (lt)
LV (1) LV12658B (lt)
MA (1) MA25590A1 (lt)
MY (1) MY129282A (lt)
NO (1) NO20011251L (lt)
NZ (1) NZ510168A (lt)
OA (1) OA11781A (lt)
PA (1) PA8481901A1 (lt)
PE (1) PE20001061A1 (lt)
PL (1) PL195574B1 (lt)
SA (1) SA99200718B1 (lt)
SK (1) SK3442001A3 (lt)
TN (1) TNSN99173A1 (lt)
TR (1) TR200101182T2 (lt)
TW (1) TWI226248B (lt)
UA (1) UA76085C2 (lt)
UY (1) UY25711A1 (lt)
WO (1) WO2000015262A1 (lt)
YU (1) YU24201A (lt)
ZA (1) ZA200101995B (lt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
HK1049621A1 (zh) 1999-06-09 2003-05-23 罗伯特‧E‧希弗斯 超临界流体辅助的喷雾和鼓泡乾燥
US6475468B2 (en) * 2001-02-15 2002-11-05 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
CA2446904A1 (en) * 2001-05-24 2003-04-03 Alexza Pharmaceuticals, Inc. Delivery of drug esters through an inhalation route
EG24184A (en) * 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
CA2465675C (en) 2001-11-20 2008-06-10 Advanced Inhalation Research, Inc. Improved particulate compositions for pulmonary delivery
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
WO2003072734A2 (en) 2002-02-25 2003-09-04 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
CA2491129A1 (en) * 2002-07-03 2004-01-15 Brigham And Women's Hospital, Inc. Central airway administration for systemic delivery of therapeutics
JP2006513238A (ja) * 2002-12-19 2006-04-20 ファルマシア・コーポレーション 吸湿性薬物を含む非‐吸湿性製剤
DE10338403A1 (de) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverformulierung, enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl]-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyrindinyl)-piperazin, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
BRPI0510119A (pt) 2004-04-23 2007-09-25 Cydex Inc formulação para dpi contendo sulfoaquil éter de ciclodextrina
UA95903C2 (ru) * 2005-02-24 2011-09-26 Дифьюжен Фармасьютикалз Ллк Транс-каротиноиды, их синтез, лекарственная форма и применение
KR20070110418A (ko) * 2005-03-09 2007-11-16 오노 야꾸힝 고교 가부시키가이샤 입자 및 그 입자를 함유하는 제제
SI2952197T1 (sl) 2005-10-26 2017-09-29 Cydex Pharmaceuticals, Inc. Sestavki sulfoalkil eter ciklodekstrina in metode priprave le-tega
US20100269819A1 (en) * 2006-08-14 2010-10-28 Sievers Robert E Human Powered Dry Powder Inhaler and Dry Powder Inhaler Compositions
CN101541311B (zh) * 2006-10-25 2013-01-23 大日本住友制药株式会社 不易结块的颗粒制剂
EP1925295A1 (de) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Stabile Pulverformulierung enthaltend ein Anticholinergikum
EP3483140A1 (en) 2007-04-13 2019-05-15 Diffusion Pharmaceuticals LLC Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease
US12370352B2 (en) 2007-06-28 2025-07-29 Cydex Pharmaceuticals, Inc. Nasal and ophthalmic delivery of aqueous corticosteroid solutions
EA201070544A1 (ru) 2007-10-31 2010-12-30 Диффьюжн Фармасьютикалз Ллс Новый класс терапевтических веществ, усиливающих диффузию низкомолекулярных соединений
ES2661215T3 (es) * 2009-05-20 2018-03-28 Aeras Composiciones víricas; inmunógenas; secadas por pulverización; estables
KR101875843B1 (ko) 2009-06-22 2018-07-06 디퓨젼 파마슈티컬즈 엘엘씨 확산 촉진 화합물 및 그 화합물 단독 또는 혈전 용해제와 합쳐진 화합물의 용도
CN105287473A (zh) 2010-06-02 2016-02-03 扩散药品有限公司 包含双极性反式类胡萝卜素的组合物及其应用
SG11201406208QA (en) 2012-05-03 2014-11-27 Janssen Sciences Ireland Uc Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections
BR112015010601B1 (pt) * 2012-11-09 2022-07-19 Civitas Therapeutics, Inc. Composição farmacêutica e uso da composição
US20180043585A9 (en) * 2013-09-20 2018-02-15 Virginia Commonwealth University Delivery of particles using hygroscopic excipients
AU2015338717B2 (en) 2014-10-31 2018-12-20 Glaxosmithkline Intellectual Property Development Limited Powder formulation
WO2017165667A1 (en) 2016-03-24 2017-09-28 Diffusion Pharmaceuticals Llc Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer
US20220378727A1 (en) * 2021-05-14 2022-12-01 The University Of Hong Kong Dry powder formulations of tamibarotene for pulmonary and intranasal delivery
EP4493276A4 (en) * 2022-03-18 2025-03-05 Pulmocures Ilac Egitim Danismanlik A.S. DOSAGE FORMS OF ACTIVE AGENTS AGAINST VIRAL DISEASES IN DRY POWDER INHALATOR DEVICES FOR SYMPTOMS DUE TO COVID-19 AND OTHER VIRAL LUNG DISEASES

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155573A (en) * 1958-05-06 1964-11-03 Benger Lab Ltd Inhalant composition and method of making same
EP0611567B1 (en) * 1992-06-12 2002-08-28 Teijin Limited Ultrafine powder for inhalation and production thereof
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
DE69732306T2 (de) * 1997-01-16 2006-01-12 Massachusetts Institute Of Technology, Cambridge Zubereitung von partikelhaltigen arzneimitteln zur inhalation
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

Also Published As

Publication number Publication date
JP2002524535A (ja) 2002-08-06
MA25590A1 (fr) 2002-12-31
WO2000015262A1 (en) 2000-03-23
YU24201A (sh) 2003-08-29
PE20001061A1 (es) 2000-10-08
MY129282A (en) 2007-03-30
IL141562A (en) 2007-07-24
CA2343920A1 (en) 2000-03-23
CN1317977A (zh) 2001-10-17
ID28845A (id) 2001-07-05
HRP20010189A2 (en) 2005-04-30
CZ2001829A3 (cs) 2001-09-12
CO5130023A1 (es) 2002-02-27
PL195574B1 (pl) 2007-10-31
LT4897B (lt) 2002-02-25
PA8481901A1 (es) 2002-04-25
LT2001021A (lt) 2001-11-26
OA11781A (en) 2005-07-26
BG105430A (en) 2001-12-29
HUP0103837A2 (hu) 2002-05-29
AP1374A (en) 2005-02-28
HK1042231A1 (zh) 2002-08-09
NZ510168A (en) 2003-09-26
ZA200101995B (en) 2002-03-11
AU753014B2 (en) 2002-10-03
TNSN99173A1 (fr) 2005-11-10
LV12658B (lv) 2001-09-20
LV12658A (lv) 2001-05-20
EP1117442A1 (en) 2001-07-25
UA76085C2 (en) 2006-07-17
GT199900156A (es) 2001-03-07
SA99200718B1 (ar) 2006-11-04
PL346768A1 (en) 2002-02-25
GEP20043257B (en) 2004-06-25
AP2001002093A0 (en) 2001-03-31
TWI226248B (en) 2005-01-11
DZ2892A1 (fr) 2003-12-15
UY25711A1 (es) 1999-11-17
NO20011251L (no) 2001-04-17
AR022090A1 (es) 2002-09-04
TR200101182T2 (tr) 2001-09-21
HUP0103837A3 (en) 2002-11-28
IL141562A0 (en) 2002-03-10
NO20011251D0 (no) 2001-03-13
IS5878A (is) 2001-03-05
EA003476B1 (ru) 2003-06-26
HN1999000159A (es) 1999-11-11
BR9913722A (pt) 2001-05-29
KR20010075063A (ko) 2001-08-09
EA200100300A1 (ru) 2001-10-22
AU6039799A (en) 2000-04-03
SK3442001A3 (en) 2001-11-06

Similar Documents

Publication Publication Date Title
LV12658A (lv) Dry powder active agent pulmonary delivery
DE60035911D1 (de) Trockenpulverinhalator
DE60141579D1 (de) Trockenpulver-Inhalator
FI19991852L (fi) Uusi monikerroksinen materiaali, joka käsittää vaikuttavan ainesosan, ja sen valmistus
EE200100212A (et) Toimeaine kohaletoimetamine aerosoolina moduleeritud takistusega õhuvooluga
DE69918074D1 (de) Makrolid-formulierung mit verzögerter wirkstoffabgabe
DK1263720T3 (da) Azetidinderivater, fremstilling deraf samt farmaceutiske sammensætninger, der indeholder samme
EE200100185A (et) Asendatud fenüülderivaadid, nende valmistamine jakasutamine
DE69928085D1 (de) Dosierungsform mit verlängerter wirkstoffabgabe
EE04219B1 (et) Säilituskindel toimeainekontsentraat formoterooliga
DE60039829D1 (de) Pulversprühpistole
IS4364A (is) Innöndunarbúnaður fyrir þurrduft
NL350038I1 (nl) Herbicidaal actieve 3-hydroxy-4-aryl-5-oxopyrazoline derivaten
NO20012915D0 (no) Ny farmasöytisk formulering
HUP0400723A3 (en) Isoxazoline derivatives and herbicide composition comprising the same as active ingredient
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
DE60005091D1 (de) Viruzide und sporizide Zusammensetzung
FIU20000164U0 (fi) Uusi farmaseuttinen formulaatio
PL366855A1 (en) Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof
HRP20040171A2 (en) Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
DE69919490D1 (de) Puder mit fettlöslichem wirkstoff
HUP0203611A3 (en) 14,15-beta-methylene substituted androgens and their use for preparation of the medicaments
DE60001266D1 (de) Betahistin-hältige formulierung mit kontrollierter wirkstofffreisetzung
HUP0104238A3 (en) Benzoxazole derivatives and drugs containing the same as the active ingredient and their use
NO20014692D0 (no) 3-amidinobenzensulfonamidderivater, medisinske sammensetninger inneholdende slike samt intermediater vedfremstillingen derav

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner